Certification Period. 3.1 During the Certification Period with respect to the United States, Schw▇▇▇ ▇▇▇rma will exert its continuing best efforts, at its expense, to prepare and file an ANDA or ANDAs for the Designated Products with the FDA and to prosecute the same successfully to the granting of an FDA license to market the Designated Product in each of the four dosage strengths. TIMERx Technologies will, promptly and throughout the Certification Period, provide to Schw▇▇▇ ▇▇▇rma all necessary information in or coming into TIMERx Technologies' possession or reasonably available to it for such purpose. Also, during the Certification Period, TIMERx Technologies will exert its continuing best efforts to qualify the manufacturing sites referred to in Section 5.2 for the manufacture of Formulated TIMERx.
Appears in 2 contracts
Sources: Product Development and Supply Agreement (Penwest Pharmaceuticals Co), Product Development and Supply Agreement (Penwest Pharmaceuticals Co)